We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 372

Actavis v Eli Lilly - should we have seen it coming?
  • Gowling WLG
  • United Kingdom
  • September 18 2017

The UK Supreme Court's 12 July 2017 judgment in Actavis v Eli Lilly is undoubtedly a landmark decision, re-steering UK law regarding patent


The Singapore Court of Appeal Rules on Post Grant Amendments to Patents and Validity of Second Medical Use Claims
  • Gowling WLG
  • European Union, Singapore, United Kingdom
  • August 11 2017

On 1 August 2017, the Singapore Court of Appeal in Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd 2017 SGCA 45 dismissed


Curtain lifted on proposed amended PM(NOC) Regulations
  • Gowling WLG
  • Canada
  • July 17 2017

The curtain has been lifted to reveal the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (the “Amended


UK Supreme Court introduces doctrine of equivalents in patent law in Actavis v Lilly
  • Gowling WLG
  • European Union, United Kingdom
  • July 13 2017

In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a


$644 million patent infringement judgment is largest in Canadian history
  • Gowling WLG
  • Canada
  • July 11 2017

In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful


Brexit - what are the implications for intellectual property?
  • Gowling WLG
  • European Union, United Kingdom
  • July 11 2017

'Brexit' poses considerable challenges for intellectual property law and presents uncertainty as to the involvement of the UK


Supreme Court of Canada rejects the Promise of the Patent Doctrine
  • Gowling WLG
  • Canada
  • June 30 2017

The Supreme Court of Canada released on June 30, 2017 its long-awaited decision (available here) addressing the issue of the "promise of the patent


Supreme Court of Canada Bulletin - June 30, 2017
  • Gowling WLG
  • Canada
  • June 30 2017

On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638


UK Parliament continues legislative steps needed for ratification of UPC Agreement
  • Gowling WLG
  • European Union, United Kingdom
  • June 27 2017

With the UK Parliament sitting again, following the drama of the June 2017 General Election, the Government is now continuing with the national


Patent exhaustion in Canada and the UK
  • Gowling WLG
  • Canada, European Union, United Kingdom
  • June 12 2017

The doctrine of “patent exhaustion” provides that once a patentee sells one of its products, it can no longer exercise control over the specific